Try our beta test site
155 studies found for:    "Meningioma"
Show Display Options
Download search resultsDownload the search results for:
"Meningioma" (155 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Carbon Ion Radiotherapy for Atypical Meningiomas
Condition: Meningioma
Intervention: Radiation: Carbon Ion Radiotherapy
2 Terminated
Has Results
Antineoplaston Therapy in Treating Patients With Meningioma
Condition: Meningioma
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
3 Completed
Has Results
Monthly SOM230C for Recurrent or Progressive Meningioma
Condition: Meningioma
Intervention: Drug: SOM230C
4 Recruiting A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma
Condition: Meningiomas
Intervention: Drug: Nivolumab
5 Completed
Has Results
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
Condition: Adult Meningioma
Intervention: Drug: hydroxyurea
6 Completed Mifepristone in Meningioma
Condition: Meningioma
Interventions: Drug: Mifepristone;   Other: Placebo
7 Active, not recruiting Multisession Radiosurgery in Large Meningiomas
Condition: Intracranial Meningioma
Intervention: Radiation: Radiotherapy
8 Not yet recruiting Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas
Condition: Meningioma
Interventions: Radiation: Radiotherapy 68 Gy(RBE);   Radiation: Radiotherapy 72 Gy(RBE);   Radiation: Radiotherapy 60 Gy(RBE)
9 Terminated
Has Results
Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
Condition: Intracranial Meningioma
Interventions: Drug: Everolimus;   Drug: Bevacizumab
10 Completed Proton/Photon Rt - Benign Meningiomas(P92-13)
Condition: Benign Meningioma
Interventions: Radiation: Standard Treatment;   Radiation: Higher Dose
11 Recruiting Trabectedin for Recurrent Grade II/III Meningioma
Condition: Recurrent High Grade Meningioma
Interventions: Drug: Trabectedin;   Other: Local standard of care
12 Recruiting Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
Conditions: Recurrent Meningiomas;   Resistant Meningiomas
Interventions: Drug: Everolimus;   Drug: Octreotide
13 Recruiting A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas
Conditions: Intracranial Meningioma;   Recurrent Meningioma
Interventions: Drug: vismodegib;   Drug: GSK2256098
14 Unknown  Randomized Comparison of Proton and Carbon Ion Radiotherapy With Advanced Photon Radiotherapy in Skull Base Meningiomas: The PINOCCHIO Trial.
Condition: Skull Base Meningioma
Interventions: Radiation: Carbon Ion Radiotherapy;   Radiation: Proton Therapy;   Radiation: Hypofractionated Photon Radiotherapy;   Radiation: Conventional Photon Radiotherapy
15 Recruiting Cavernous Sinus Dissection and Bleeding in Meningiomas
Condition: Meningiomas of the Middle Cranial Fossa
Intervention: Other: surgery
16 Completed A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
Condition: Meningioma
Interventions: Drug: prophylactic enoxaparin;   Procedure: non-prophylactic
17 Recruiting A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
Conditions: Meningioma;   Brain Tumor
Intervention: Radiation: Intensity Modulated Proton Therapy (IMPT)
18 Recruiting Proton Radiation For Meningiomas and Hemangiopericytomas
Condition: Patients With a Diagnosis of WHO Grade I-III Meningioma and Hemangiopericytoma With Adequate Bone Marrow Function
Intervention: Radiation: Proton Radiation
19 Recruiting Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
Conditions: Glioblastoma Multiforme;   Meningioma
Intervention: Drug: Ribociclib
20 Unknown  Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery
Conditions: Intracranial Meningioma;   Neurologic Deficits
Intervention: Biological: HBOT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.